PHARMACODYNAMIC DEMONSTRATION OF IMMUNOLOGICAL TOLERANCE INDUCED BY KAN-101, A NOVEL LIVER-TARGETED THERAPY FOR COELIAC DISEASE, PERSISTS FOLLOWING DRUG CLEARANCE

KAN-101 - Anokion

J.A. Murray1; D. Wassaf2; S. Morgan2; S. Kontos2; K. Goldstein2; T. Thornley2; K. Grebe2

Jul 9, 2023